AngioDynamics Capital Expenditures vs Net Income Analysis

ANGO Stock

USD 9.11 0.22 2.47%

AngioDynamics financial indicator trend analysis is way more than just evaluating AngioDynamics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AngioDynamics is a good investment. Please check the relationship between AngioDynamics Capital Expenditures and its Net Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

Capital Expenditures vs Net Income

Capital Expenditures vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AngioDynamics Capital Expenditures account and Net Income. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between AngioDynamics' Capital Expenditures and Net Income is -0.1. Overlapping area represents the amount of variation of Capital Expenditures that can explain the historical movement of Net Income in the same time period over historical financial statements of AngioDynamics, assuming nothing else is changed. The correlation between historical values of AngioDynamics' Capital Expenditures and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Expenditures of AngioDynamics are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Capital Expenditures i.e., AngioDynamics' Capital Expenditures and Net Income go up and down completely randomly.

Correlation Coefficient

-0.1

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Capital Expenditures

Capital Expenditures are funds used by AngioDynamics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of AngioDynamics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in AngioDynamics financial statement analysis. It represents the amount of money remaining after all of AngioDynamics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most indicators from AngioDynamics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AngioDynamics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.At this time, AngioDynamics' Discontinued Operations is very stable compared to the past year. As of the 12th of December 2024, Enterprise Value is likely to grow to about 335.7 M, while Selling General Administrative is likely to drop about 28.3 M.

	2021	2022	2023	2024 (projected)
Gross Profit	165.7M	174.2M	154.7M	131.3M
Total Revenue	316.2M	338.8M	303.9M	246.7M

Gross Profit Total Revenue

AngioDynamics fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets
Common Stock Shares Outstanding		0.57	0.12	0.35	0.86	0.6	0.49	0.16	-0.13	-0.2	0.58	0.34	0.46	0.13	0.12	0.31	0.65	0.94	-0.34	0.24	0.78	0.11	0.95	0.45	0.34	0.64
Total Assets	0.57		0.8	-0.1	0.49	0.99	0.69	0.41	0.43	0.5	0.27	0.27	0.92	0.0	0.77	0.28	0.75	0.59	0.18	0.84	0.65	0.04	0.63	0.92	0.04	0.6
Short Long Term Debt Total	0.12	0.8		-0.4	0.23	0.72	0.63	0.33	0.74	0.79	0.14	0.07	0.87	-0.11	0.93	0.07	0.61	0.19	0.39	0.96	0.39	0.03	0.2	0.9	-0.22	0.31
Other Current Liab	0.35	-0.1	-0.4		0.53	-0.09	0.05	-0.59	-0.56	-0.72	0.58	0.31	-0.36	0.13	-0.23	0.33	0.24	0.38	-0.17	-0.4	0.1	0.37	0.39	-0.13	0.65	0.41
Total Current Liabilities	0.86	0.49	0.23	0.53		0.47	0.6	-0.11	-0.04	-0.25	0.84	0.32	0.38	0.17	0.3	0.3	0.79	0.91	-0.08	0.25	0.75	0.4	0.89	0.5	0.5	0.68
Total Stockholder Equity	0.6	0.99	0.72	-0.09	0.47		0.62	0.47	0.34	0.47	0.22	0.32	0.88	0.03	0.68	0.33	0.7	0.61	0.17	0.76	0.62	0.02	0.66	0.85	0.02	0.63
Property Plant And Equipment Net	0.49	0.69	0.63	0.05	0.6	0.62		-0.14	0.68	0.17	0.59	-0.31	0.71	0.16	0.66	-0.3	0.88	0.59	0.32	0.67	0.8	0.45	0.58	0.79	0.45	0.18
Current Deferred Revenue	0.16	0.41	0.33	-0.59	-0.11	0.47	-0.14		0.05	0.63	-0.42	0.37	0.48	-0.14	0.17	0.35	-0.07	0.08	-0.07	0.34	0.0	-0.31	0.11	0.21	-0.49	0.26
Net Debt	-0.13	0.43	0.74	-0.56	-0.04	0.34	0.68	0.05		0.62	0.04	-0.61	0.66	-0.14	0.63	-0.61	0.46	-0.06	0.48	0.74	0.35	0.16	-0.06	0.61	-0.11	-0.34
Retained Earnings	-0.2	0.5	0.79	-0.72	-0.25	0.47	0.17	0.63	0.62		-0.34	0.05	0.7	-0.31	0.58	0.03	0.1	-0.22	0.29	0.76	-0.06	-0.28	-0.19	0.53	-0.67	0.02
Accounts Payable	0.58	0.27	0.14	0.58	0.84	0.22	0.59	-0.42	0.04	-0.34		0.08	0.19	0.23	0.23	0.08	0.71	0.69	0.14	0.13	0.66	0.61	0.68	0.35	0.52	0.45
Cash	0.34	0.27	0.07	0.31	0.32	0.32	-0.31	0.37	-0.61	0.05	0.08		0.05	0.03	0.14	1.0	-0.01	0.32	-0.25	0.04	-0.08	-0.21	0.31	0.13	-0.15	0.86
Non Current Assets Total	0.46	0.92	0.87	-0.36	0.38	0.88	0.71	0.48	0.66	0.7	0.19	0.05		-0.13	0.73	0.03	0.69	0.48	0.25	0.92	0.61	-0.01	0.51	0.89	-0.17	0.36
Other Assets	0.13	0.0	-0.11	0.13	0.17	0.03	0.16	-0.14	-0.14	-0.31	0.23	0.03	-0.13		0.06	0.07	0.1	0.22	0.15	-0.2	0.15	0.21	0.2	-0.07	0.35	0.13
Long Term Debt	0.12	0.77	0.93	-0.23	0.3	0.68	0.66	0.17	0.63	0.58	0.23	0.14	0.73	0.06		0.16	0.63	0.26	0.44	0.88	0.44	0.17	0.23	0.9	0.03	0.42
Cash And Short Term Investments	0.31	0.28	0.07	0.33	0.3	0.33	-0.3	0.35	-0.61	0.03	0.08	1.0	0.03	0.07	0.16		0.0	0.31	-0.2	0.04	-0.08	-0.18	0.3	0.13	-0.11	0.86
Net Receivables	0.65	0.75	0.61	0.24	0.79	0.7	0.88	-0.07	0.46	0.1	0.71	-0.01	0.69	0.1	0.63	0.0		0.72	0.18	0.61	0.83	0.51	0.73	0.79	0.46	0.48
Common Stock Total Equity	0.94	0.59	0.19	0.38	0.91	0.61	0.59	0.08	-0.06	-0.22	0.69	0.32	0.48	0.22	0.26	0.31	0.72		-0.04	0.27	0.86	0.31	0.99	0.49	0.44	0.69
Short Term Investments	-0.34	0.18	0.39	-0.17	-0.08	0.17	0.32	-0.07	0.48	0.29	0.14	-0.25	0.25	0.15	0.44	-0.2	0.18	-0.04		0.27	0.13	0.44	-0.05	0.21	-0.01	-0.07
Non Current Liabilities Total	0.24	0.84	0.96	-0.4	0.25	0.76	0.67	0.34	0.74	0.76	0.13	0.04	0.92	-0.2	0.88	0.04	0.61	0.27	0.27		0.47	-0.05	0.28	0.94	-0.2	0.31
Inventory	0.78	0.65	0.39	0.1	0.75	0.62	0.8	0.0	0.35	-0.06	0.66	-0.08	0.61	0.15	0.44	-0.08	0.83	0.86	0.13	0.47		0.42	0.84	0.64	0.43	0.4
Other Current Assets	0.11	0.04	0.03	0.37	0.4	0.02	0.45	-0.31	0.16	-0.28	0.61	-0.21	-0.01	0.21	0.17	-0.18	0.51	0.31	0.44	-0.05	0.42		0.28	0.08	0.67	0.1
Other Stockholder Equity	0.95	0.63	0.2	0.39	0.89	0.66	0.58	0.11	-0.06	-0.19	0.68	0.31	0.51	0.2	0.23	0.3	0.73	0.99	-0.05	0.28	0.84	0.28		0.5	0.4	0.68
Total Liab	0.45	0.92	0.9	-0.13	0.5	0.85	0.79	0.21	0.61	0.53	0.35	0.13	0.89	-0.07	0.9	0.13	0.79	0.49	0.21	0.94	0.64	0.08	0.5		0.08	0.49
Property Plant And Equipment Gross	0.34	0.04	-0.22	0.65	0.5	0.02	0.45	-0.49	-0.11	-0.67	0.52	-0.15	-0.17	0.35	0.03	-0.11	0.46	0.44	-0.01	-0.2	0.43	0.67	0.4	0.08		0.15
Total Current Assets	0.64	0.6	0.31	0.41	0.68	0.63	0.18	0.26	-0.34	0.02	0.45	0.86	0.36	0.13	0.42	0.86	0.48	0.69	-0.07	0.31	0.4	0.1	0.68	0.49	0.15

Click cells to compare fundamentals

AngioDynamics Account Relationship Matchups

AngioDynamics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	38.0M	38.3M	39.0M	39.5M	40.2M	30.0M
Total Assets	595.5M	561.4M	552.8M	532.6M	317.7M	525.4M
Short Long Term Debt Total	40.8M	22.4M	33.8M	64.6M	5.9M	5.6M
Other Current Liab	2.1M	38.0M	43.0M	43.4M	50.9M	53.5M
Total Current Liabilities	51.5M	57.6M	74.3M	83.8M	91.2M	50.9M
Total Stockholder Equity	455.9M	439.5M	424.5M	378.3M	205.6M	396.5M
Property Plant And Equipment Net	28.3M	37.1M	45.0M	44.4M	41.5M	35.4M
Net Debt	(13.6M)	(28.2M)	5.0M	5.2M	(71.3M)	(67.8M)
Retained Earnings	(100.3M)	(131.9M)	(158.4M)	(210.9M)	(395.2M)	(375.4M)
Accounts Payable	19.1M	19.6M	28.0M	40.4M	37.8M	19.0M
Cash	54.4M	48.2M	28.8M	44.6M	76.1M	47.3M
Non Current Assets Total	442.6M	420.6M	409.4M	369.1M	124.4M	118.2M
Other Assets	5.2M	3.8M	11.0M	49.2M	56.6M	59.4M
Long Term Debt	40M	20M	25M	49.8M	57.3M	58.7M
Cash And Short Term Investments	54.4M	48.2M	28.8M	44.6M	76.1M	62.7M
Net Receivables	31.3M	35.4M	52.3M	52.8M	43.6M	38.7M
Common Stock Total Equity	374K	377K	380K	382K	439.3K	308.9K
Liabilities And Stockholders Equity	595.5M	561.4M	552.8M	532.6M	317.7M	525.4M
Non Current Liabilities Total	88.1M	64.4M	53.9M	70.5M	20.9M	19.9M
Inventory	59.9M	48.6M	51.4M	55.3M	60.6M	43.6M
Other Current Assets	2.2M	1.8M	14.5M	4.6M	13.0M	7.1M
Other Stockholder Equity	557.2M	567.8M	581.2M	593.5M	604.8M	434.9M
Total Liab	139.6M	122.0M	128.3M	154.3M	112.1M	128.9M
Property Plant And Equipment Gross	28.3M	37.1M	96.1M	44.4M	108.7M	114.1M
Total Current Assets	152.9M	140.9M	143.3M	163.5M	193.3M	153.9M
Accumulated Other Comprehensive Income	(1.3M)	3.2M	1.4M	(4.7M)	(4.4M)	(4.1M)
Short Term Debt	836K	2.4M	2.6M	14.8M	2.0M	1.9M
Intangible Assets	197.1M	169.0M	152.4M	111.1M	77.4M	112.1M
Common Stock	374K	377K	380K	382K	385K	314.6K
Property Plant Equipment	28.3M	37.1M	45.0M	44.4M	51.0M	34.9M
Non Currrent Assets Other	15.6M	13.2M	(5.1M)	54.3M	5.6M	7.4M
Other Liab	39.6M	37.1M	24.2M	17.4M	20.0M	32.6M
Good Will	347.7M	201.5M	201.3M	201.1M	159.2M	0.0
Net Tangible Assets	57.2M	69.2M	71.1M	378.3M	435.0M	456.8M
Retained Earnings Total Equity	(100.3M)	(131.9M)	(158.4M)	(210.9M)	(189.8M)	(180.3M)
Long Term Debt Total	40M	20M	25M	49.8M	44.8M	69.2M
Capital Surpluse	561.9M	573.5M	586.9M	599.2M	689.1M	600.4M
Deferred Long Term Liab	24.1M	20.0M	16.0M	12.8M	14.7M	14.1M

Pair Trading with AngioDynamics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.

Moving against AngioDynamics Stock

0.5	VNRX	Volitionrx	Pair Corr
0.45	DRIO	DarioHealth Corp	Pair Corr

The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.

The correlation of AngioDynamics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:

How To Invest In AngioDynamics

Details

Is AngioDynamics Stock a good investment?

Details

What is AngioDynamics' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(6.05)

Revenue Per Share

7.249

Quarterly Revenue Growth

(0.14)

Return On Assets

(0.06)

Return On Equity

(0.78)

The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

AngioDynamics Capital Expenditures vs Net Income Analysis

Capital Expenditures vs Net Income

Capital Expenditures vs Net Income Correlation Analysis

Correlation Coefficient

Capital Expenditures

Net Income

AngioDynamics fundamental ratios Correlations

AngioDynamics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

AngioDynamics fundamental ratios Accounts

Pair Trading with AngioDynamics

Moving against AngioDynamics Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.99	Total Assets
Other Stockholder Equity	+ 0.99	Common Stock Total Equity
Non Current Liabilities Total	+ 0.96	Short Long Term Debt Total
Other Stockholder Equity	+ 0.95	Common Stock Shares Outstanding
Common Stock Total Equity	+ 0.94	Common Stock Shares Outstanding

Retained Earnings	- 0.72	Other Current Liab
Property Plant And Equipment Gross	- 0.67	Retained Earnings
Cash And Short Term Investments	- 0.61	Net Debt
Cash	- 0.61	Net Debt
Current Deferred Revenue	- 0.59	Other Current Liab
Net Debt	- 0.56	Other Current Liab